ALTERNATING COMBINATION CHEMOTHERAPY (VMCP/VBAP) IS NOT SUPERIOR TO MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA PATIENTS STAGE-III - A RANDOMIZED STUDY FROM MGCS

被引：0

作者：

OSTERBORG, A

AHRE, A

BJORKHOLM, M

BJOREMAN, M

BRENNING, G

GAHRTON, G

GYLLENHAMMAR, H

JOHANSSON, B

JULIUSSON, G

JARNMARK, M

KILLANDER, A

KIMBY, E

LERNER, R

NILSSON, B

PAUL, C

SIMONSSON, B

STALFELT, AM

STRANDER, H

SMEDMYR, B

SVEDMYR, E

UDEN, AM

WADMAN, B

WEDELIN, C

MELLSTEDT, H

机构：

[1] KAROLINSKA HOSP, RADIUM HEMMET, DEPT BIOSTAT, S-10401 STOCKHOLM, SWEDEN

[2] KAROLINSKA HOSP, RADIUM HEMMET, DEPT MED, S-10401 STOCKHOLM, SWEDEN

[3] DANDERYD HOSP, DEPT MED, S-18288 DANDERYD, SWEDEN

[4] SODER SJUKHUSET, DEPT MED, STOCKHOLM, SWEDEN

[5] HUDDINGE HOSP, DEPT MED, STOCKHOLM, SWEDEN

[6] ACAD HOSP UPPSALA, DEPT MED, S-75014 UPPSALA, SWEDEN

[7] OREBRO MED CTR HOSP, DEPT MED, OREBRO, SWEDEN

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 1989年 / 43卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：54 / 62

页数：9

共 39 条

[1] MULTIPLE-MYELOMA - VMCP/VBAP ALTERNATING COMBINATION CHEMOTHERAPY IS NOT SUPERIOR TO MELPHALAN AND PREDNISONE EVEN IN HIGH-RISK PATIENTS
BOCCADORO, M
MARMONT, F
TRIBALTO, M
AVVISATI, G
ANDRIANI, A
BARBUI, T
CANTONETTI, M
CAROTENUTO, M
COMOTTI, B
DAMMACCO, F
FRIERI, R
GALLAMINI, A
GALLONE, G
GIOVANGROSSI, P
GRIGNANI, F
LAUTA, VM
LIBERATI, M
MUSTO, P
NERETTO, G
PETRUCCI, MT
RESEGOTTI, L
PILERI, A
MANDELLI, F
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) : 444 - 448
[2] ALTERNATING COMBINATION VCMP VBAP CHEMOTHERAPY VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED MULTICENTRIC STUDY OF 487 PATIENTS
BLADE, J
SANMIGUEL, JF
ALCALA, A
MALDONADO, J
SANZ, MA
GARCIACONDE, J
MORO, MJ
ALONSO, C
BESALDUCH, J
ZUBIZARRETA, A
BESSES, C
GONZALEZBRITO, G
HERNANDEZMARTIN, J
FERNANDEZCALVO, J
RUBIO, D
ORTEGA, F
JIMENEZ, R
COLOMINAS, P
FAURA, MV
FONT, L
TORTOSA, J
DOMINGO, A
FONTANILLAS, M
ROZMAN, C
ESTAPE, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1165 - 1171
[3] A RANDOMIZED MULTICENTRIC STUDY COMPARING ALTERNATING COMBINATION CHEMOTHERAPY (VCMP VBAP) AND MELPHALAN-PREDNISONE IN MULTIPLE-MYELOMA
BLADE, J
MIGUEL, JS
ALCALA, A
MALDONADO, J
GARCIACONDE, J
MORO, MJ
SANZ, MAS
ALONSO, C
ZUBIZARRETA, A
BESSES, C
MARTIN, JMH
BESALDUCH, J
NIETO, LH
CALVO, JF
RUBIO, D
MAYANS, JR
SANCHIS, J
GALINDO, RJ
TORTOSA, J
ORTEGA, F
DOMINGO, A
FAURA, MV
DANIELS, M
ROZMAN, C
ESTAPE, J
[J]. BLUT, 1990, 60 (06): : 319 - 322
[4] NATURAL INTERFERON-ALPHA IN COMBINATION WITH MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA STAGE-II AND STAGE-III - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
OSTERBORG, A
BJORKHOLM, M
BJOREMAN, M
BRENNING, G
CARLSON, K
CELSING, F
GAHRTON, G
GRIMFORS, G
GYLLENHAMMAR, H
HAST, R
JOHANSSON, B
JULIUSSON, G
JARNMARK, M
KIMBY, E
LERNER, R
LINDER, O
MERK, K
NILSSON, B
OHRLING, M
PAUL, C
SIMONSSON, B
SMEDMYR, B
SVEDMYR, E
STALFELT, AM
STRANDER, H
UDEN, AM
OSBY, E
MELLSTEDT, H
[J]. BLOOD, 1993, 81 (06) : 1428 - 1434
[5] MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE PLUS HUMAN ALPHA INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA, STAGE-II AND STAGE-III
BJORKHOLM, M
MELLSTEDT, H
OSTERBORG, A
BJOREMAN, M
LERNER, R
MERK, K
BRENNING, G
OHRLING, M
GAHRTON, G
SIMONSSON, B
GRIMFORS, G
SMEDMYR, B
GYLLENHAMAR, H
STALFELT, A
HAST, R
STRANDER, H
JULIUSSON, G
SVEDMYR, E
JARNMARK, M
UDEN, A
KILLANDER, A
WADMAN, B
KIMBY, E
OSBY, E
[J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 : S51 - S52
[6] EFFECTIVENESS OF 2-STAGE TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND WITH MELPHALAN IN COMBINATION WITH CYCLOPHOSPHAMIDE, CARMUSTINE, VINCRISTINE AND PREDNISONE
SNIGUROWICZ, J
KRAJ, M
ROSTKOWSKA, J
MAJ, S
MARIANSKA, B
MENDEK, E
ROSZKOWSKI, S
KILIAN, Z
KOLAKOWSKI, L
[J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (02) : 145 - 153
[7] MANAGEMENT OF STAGE-II AND STAGE-III MULTIPLE-MYELOMA WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU (PROTOCOL M-2)
MONTALBAN, C
SEVILLA, F
ZAPATERO, A
BLANCO, L
SABAN, J
SERRANO, M
RIOS, MS
[J]. REVISTA CLINICA ESPANOLA, 1985, 176 (08): : 392 - 395
[8] ORAL VERSUS INTRAVENOUS MELPHALAN AND PREDNISONE TREATMENT IN MULTIPLE-MYELOMA STAGE-II - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
OSTERBORG, A
AHRE, A
BJORKHOLM, M
BJOREMAN, M
BRENNING, G
GAHRTON, G
GRIMFORS, G
GYLLENHAMMAR, H
HAST, R
JOHANSSON, B
JULIUSSON, G
JARNMARK, M
KILLANDER, A
KIMBY, E
LERNER, R
NILSSON, B
PAUL, C
SIMONSSON, B
STALFELT, AM
SMEDMYR, B
SVEDMYR, E
UDEN, AM
WADMAN, B
OSBY, E
MELLSTEDT, H
[J]. ACTA ONCOLOGICA, 1990, 29 (06) : 727 - 731
[9] TREATMENT OF MULTIPLE-MYELOMA WITH AN INTENSIVE 5-DRUG COMBINATION OR INTERMITTENT MELPHALAN AND PREDNISONE - A RANDOMIZED MULTICENTER TRIAL
PALVA, IP
AHRENBERG, P
ALAHARJA, K
ALMQVIST, A
APAJALAHTI, J
HALLMAN, H
HANNINEN, A
ILVONEN, M
ISOMAA, B
JARVENPAA, E
JARVENTIE, G
KILPI, H
KOISTINEN, S
KORPI, E
KOIVUNEN, E
KATKA, K
LAHTINEN, R
LAITINEN, A
LEHTINEN, M
MAKELA, H
NYLANDEN, P
OIVANEN, T
PELLINIEMI, TT
PULLI, T
RAJAMAKI, A
ROSENGARD, S
TIMONEN, T
WARIS, E
WASASTJERNA, C
VILPO, J
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (01) : 50 - 54
[10] VINCRISTINE, BCNU, DOXORUBICIN, AND PREDNISONE (VBAP) COMBINATION IN THE TREATMENT OF RELAPSING OR RESISTANT MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
BONNET, J
ALEXANIAN, R
SALMON, S
BOTTOMLEY, R
AMARE, M
HAUT, A
DIXON, D
[J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1267 - 1271

← 1 2 3 4 →